IAC 2006, Toronto
The 16th International AIDS Conference (IAC) was held in Toronto in August 2006.
-
13-18 August 2006
-
Toronto, Canada
Botswana’s adult HIV mortality rate falls since the rollout of free antiretroviral therapy
Over 40% of HIV-infected gay men in UK unaware of status; more than half believe they are HIV-negative
Is serosorting working, or even possible?
Pre-exposure prophylaxis ‘would be cost-effective’ if more than 50% efficacious
HIV/HCV coinfected patients more prone to end-stage liver disease without treatment
MK-0518 integrase inhibitor effective in treatment-naive patients
The limits of PEP: saturation knowledge does not mean saturation use
Access to treatment associated with declining stigma in Botswana
TNX-355, new entry inhibitor, effective in highly treatment-experienced patients
Kaletra monotherapy as effective as triple therapy for at least 18 months
Efavirenz more durable than Kaletra over two years in treament-naive patients
Vicriviroc effective in treatment-experienced patients, but malignancy questions remain unanswered
Maraviroc raises CD4 counts in patients with mixed-tropism virus, may offer value for highly treatment-experienced
Merck launches expanded access programme for integrase inhibitor
New data shed light on poor outcome in SMART study
-
17 August 2006